• FK866 (APO866): NAMPT Inhibition in Cancer and Host Immunity

  2026-07-08

  Explore the unique dual role of FK866 (APO866) as a NAMPT inhibitor in both hematologic cancer research and innate immune modulation. This in-depth analysis connects NAD metabolism, mitochondrial dynamics, and host-pathogen interactions to offer fresh insights beyond standard cancer workflows.

• Hexa-acylated LPS from Gut Microbiota Boosts Cancer Immunoth

  2026-07-07

  This study uncovers how specific hexa-acylated lipopolysaccharides (LPS) from gut bacteria enhance the efficacy of anti-PD-1 cancer immunotherapy. By functionally analyzing patient microbiomes and in vivo models, the research demonstrates that not all LPS are equal—hexa-acylated structures play a pivotal, immunostimulatory role, with important implications for biomarker development and experimental design.

• Minocycline HCl in Neuroinflammation: Protocols & Insights

  2026-07-07

  Minocycline HCl uniquely bridges antimicrobial activity and neuroprotection, enabling advanced experimental workflows in inflammation and retinal degeneration models. This article distills practical protocols, troubleshooting strategies, and comparative insights for leveraging minocycline hydrochloride in cutting-edge neuroinflammatory research.

• Efficacy of Fumagillin and Antiprotozoals Against A. hoyamus

  2026-07-06

  This study systematically evaluated Fumagillin and other antiprotozoal agents for their ability to inhibit Azumiobodo hoyamushi, the causative agent of soft tunic syndrome in Halocynthia roretzi. The findings define comparative potencies and highlight protocol considerations for disease management and research applications.

• Plant Autophagy: VPS41-Driven Vacuole Conversion Pathway Rev

  2026-07-06

  Jiang et al. (2024) uncover a plant-specific pathway in Arabidopsis where VPS41 transitions from condensates to phagic vacuole-associated structures, enabling autophagosome degradation independently of the RAB7 route. This mechanistic advance refines our understanding of plant autophagy and offers a new framework for dissecting vacuolar transport and degradation events.

• FITC-Concanavalin A (ConA) Conjugate: Technical Use and Prot

  2026-07-05

  FITC-Concanavalin A (ConA) Conjugate provides reliable, fluorescence-based detection of α-D-glucose and α-D-mannose on cell surfaces in immunofluorescence and flow cytometry workflows. It should be used exclusively for carbohydrate-targeted applications and is not suitable for non-glycan or unlabeled lectin protocols.

• Transdermal HA-LNP Delivery of PTEN mRNA for Melanoma Immuno

  2026-07-04

  The reference study presents a hyaluronated lipid nanoparticle (HA-LNP) system for transdermal delivery of PTEN tumor suppressor gene mRNA, targeting melanoma. This approach restores PTEN expression, enhances immune activation, and suppresses tumor growth, offering a promising alternative to conventional systemic therapies.

• Short-Scale Break-Induced Replication in Mouse Oocytes: Mech

  2026-07-03

  This study reveals that double-strand breaks (DSBs) in fully grown mouse oocytes trigger a distinctive short-scale break-induced replication (ssBIR) process, dependent on Rad51 and DNA polymerase activity. The findings clarify when and how microhomology-mediated BIR (mmBIR) is initiated in mammalian germ cells, with implications for genome stability, disease, and advanced molecular assays.

• Pazopanib Hydrochloride: Protocol Innovations in Cancer Rese

  2026-07-03

  Pazopanib Hydrochloride (GW786034) enables refined control over angiogenesis and tumor growth evaluation in preclinical cancer models. This article provides actionable protocol enhancements, troubleshooting strategies, and comparative workflow insights for maximizing experimental power and reproducibility in oncology research.

• Strategic Deployment of RG7388: Advancing p53-Driven Cancer

  2026-07-02

  This thought-leadership article explores the evolving paradigm of p53 pathway reactivation in oncology, spotlighting RG7388—a next-generation, highly selective MDM2 antagonist. By integrating mechanistic insights, translational strategies, and the latest biomarker-driven advances such as the MDM1-p53 axis, we provide a roadmap for researchers aiming to overcome resistance in solid and hematological tumors. This piece extends the discussion beyond typical product pages, offering protocol guidance, evidence-based context, and actionable perspectives for the translational research community.

• Fenofibrate and PPARα-YAP Signaling: Beyond Liver Growth Mod

  2026-07-02

  Explore how Fenofibrate, a potent PPARα agonist, uniquely informs lipid metabolism and cancer biology research. This article offers a deep dive into mechanistic insights and practical assay guidance, surpassing conventional summaries of the PPARα-YAP pathway.

• I-BET151 (GSK1210151A): Practical Guide for BET Inhibition A

  2026-07-01

  I-BET151 (GSK1210151A) enables reliable inhibition of BET bromodomains, supporting precise apoptosis and cell cycle arrest assays in cancer biology research. This product is designed for basic laboratory studies—its use is not intended for diagnostic or therapeutic applications.

• Dimetridazole: Protocol-Driven Strategies for Antimicrobial

  2026-07-01

  Dimetridazole, a 1,2-Dimethyl-5-nitroimidazole, stands out in antimicrobial research for its dual action as both a potent membrane disruptor and quorum sensing inhibitor, especially in synergy with cefotaxime against MDR E. coli. This article delivers actionable workflows, troubleshooting guidance, and translational advantages for leveraging Dimetridazole in advanced bacterial culture and infection model assays.

• TG003 Cdc2-like Kinase Inhibitor: Deep Dive into Splicing an

  2026-06-30

  Explore the scientific foundations and unique research applications of TG003, a potent Cdc2-like kinase inhibitor. This article uncovers mechanistic insights and practical assay guidance for advanced alternative splicing and platinum resistance research.

• 2X HyperFusion High-Fidelity Master Mix: Precision PCR for C

  2026-06-30

  Harness the robust fidelity and speed of the 2X HyperFusion High-Fidelity Master Mix for critical cloning, CRISPR, and immunogenomics workflows. This advanced PCR master mix from APExBIO empowers researchers with ultra-low error rates, reliable blunt-end PCR products, and seamless integration into high-demand applications.

451 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page